5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.32%
Negative revenue growth while VALMT.HE stands at 45.44%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.80%
Negative gross profit growth while VALMT.HE is at 17.14%. Joel Greenblatt would examine cost competitiveness or demand decline.
86.36%
EBIT growth above 1.5x VALMT.HE's 30.56%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
86.36%
Operating income growth above 1.5x VALMT.HE's 30.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
400.00%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
333.33%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
333.33%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
23.08%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
23.08%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-192.65%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-324.78%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-13.56%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-13.56%
Negative 5Y CAGR while VALMT.HE stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-13.56%
Negative 3Y CAGR while VALMT.HE stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-179.07%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-179.07%
Negative 5Y OCF/share CAGR while VALMT.HE is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-179.07%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
160.54%
10Y net income/share CAGR of 160.54% while VALMT.HE is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
160.54%
Net income/share CAGR of 160.54% while VALMT.HE is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
160.54%
3Y net income/share CAGR of 160.54% while VALMT.HE is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
-3.23%
Negative equity/share CAGR over 10 years while VALMT.HE stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-3.23%
Negative 5Y equity/share growth while VALMT.HE is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-3.23%
Negative 3Y equity/share growth while VALMT.HE is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.70%
Inventory growth of 3.70% while VALMT.HE is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-2.95%
Negative asset growth while VALMT.HE invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-14.94%
We have a declining book value while VALMT.HE shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-3.14%
We’re deleveraging while VALMT.HE stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.